Clinical Trial Update: Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only [Phase 4]

View source ↗

Summary

Phase 4 study evaluating replacement of nucleoside/nucleotide reverse transcriptase inhibitors with nevirapine in HIV patients on triple therapy with analogues.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viramune (Nevirapine)

Snippet

Sponsor: Hospital de Calella | Conditions: HIV Infections | Phase 4 | Status: COMPLETED